DWTX — Dogwood Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Dogwood Therapeutics Announces Pricing Of $4.8 Million Registered Direct Offering Of Common Stock Priced At-The-Market Under Nasdaq Rules
U.S. STOCKS ON THE MOVE-HubSpot, Casey's General Stores, ANI Pharma
U.S. STOCKS ON THE MOVE-Corvus, Dogwood Therapeutics, Uranium Energy
Brief: Dogwood Therapeutics converts existing debt to equity
Dogwood Therapeutics climbs after shareholder swaps debt for equity
Dogwood Therapeutics Inc expected to post a loss of $1.41 a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Low Dose IMC-2 Treatment
Dogwood Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Dogwood Therapeutics Announces Third Quarter 2024 Financial Results
Dogwood Therapeutics Inc expected to post a loss of $1.18 a share - Earnings Preview
Brief: Virios Therapeutics And Wex Pharmaceuticals Announce Business Combination To Form Dogwood Therapeutics
Virios Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Virios Therapeutics Q2 EPS USD -0.05
Virios Therapeutics Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Virios Therapeutics Completes Enrollment In IMC-2 Phase 2 Long-COVID Study
Brief: Virios Therapeutics Announces Pricing Of $1.7 Million Public Offering Of Common Stock
Brief: Virios Therapeutics Says Intends To Offer And Sell $2.1 Mln In Shares Of Its Common Stock
Virios Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Virios Therapeutics Q1 EPS USD -0.07